Graves병 관해의 예측 지표

참고문헌 (Reference)

1 조보연, "임상갑상선학." 279-342, 2005

2 대한소아내분비학회, "소아내분비학." 광문출판사 136-142, 2004

3 김호성, "소아 갑상선 기능 항진증의 치료." 4 : 10-13, 1999

4 Izumi Y, "Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease." 52 : 493-497, 2005

5 Zouvanis M, "Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy." 21 : 771-774, 1998

6 Lazar L, "Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients." 85 : 3678-3682, 2000

7 Jaruratanasirikul S, "Thyrotoxicosis in children: treatment and outcome." 89 : 967-973, 2006

8 Michelangeli V, "The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs." 8 : 119-124, 1998

9 De Groot L.J, "The cause of autoimmune thyroid disease." 10 : 537-562, 1989

10 Pujol P, "TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates." 48 : 635-640, 1998

11 Okamoto Y, "TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs." 53 : 467-472, 2006

12 Takasu I, "Simple and reliable method for predicting the Graves' disease; Revised triiodothyronine suppression test, indexed by serum thyroxine." 18 : 288-294, 1995

13 Benker G, "Response to methimazole in Graves' disease." 43 : 257-263, 1995

14 Collen R.J, "Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs." 65 : 550-556, 1980

15 Bolanos F, "Remission of Graves' hyperthyroidism treated with methimazole." 54 : 307-310, 2002

16 Takasu N, "Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment." 10 : 891-896, 2000

17 Komiya I, "Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13." 86 : 3540-3544, 2001

18 Schott M, "Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease." 37 : 741-744, 2005

19 Orgiazzi J, "Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease." 12 : 849-853, 2002

20 Schleusener H, "Prospective multicenter study on prediction of relapse after antithyroid drug treatment in patients with Graves' disease." 120 : 689-701, 1989

21 Heshmati H.M, "Prognostic value of suppressed thyrotropin level and positive thyrotropin- receptor antibody activity in Graves' disease with long-lasting clinical remission." 3 : 113-117, 1997

22 Glaser N.S, "Predictors of early remission of hyperthyroidism in children." 82 : 1719-1726, 1997

23 Glaser N.S, "Predictors of early remission of hyperthyroidism in children." 82 : 1719-1726, 1997

24 Wallaschofski H, "Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment." 34 : 383-388, 2002

25 Young E.T, "Prediction of remission after antithyroid drug treatment in Graves' disease." 66 : 175-189, 1988

26 Saleh A, "Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography." 112 : 510-513, 2004

27 Jonas M, "Predicting a relapse of Graves' hyperthyroidism in adults during the early phase of treatment with anti- thyroid drugs." 57 : 596-604, 2006

28 Kashiwai T, "Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease." 50 : 45-49, 2003

29 Raber W, "Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine." 142 : 117-124, 2000

30 Wille T, "Long- term follow up after antithyroid drug treatment in Graves' disease." 95 : 1121-1127, 2006

31 Schott M, "Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease." 36 : 92-96, 2004

32 Benker G, "Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs." 49 : 451-457, 1998

33 Schott M, "Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies." 39 : 56-61, 2007

34 Lippe B.M, "Hyperthyroidism in children treated with long term medical therapy; twenty-five percent remission every two years." 64 : 1241-1245, 1987

35 Barrio R, "Graves' disease in children and adolescents: response to long-term treatment." 94 : 1583-1589, 2005

36 Mussa G.C, "Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years." 12 : 537-541, 1999

37 Cho B.Y, "Evaluation of serum basal thyrotropin levels and thyrotopin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease." 36 : 585-590, 1992

38 DeGroot L.J, "Endocrinology." 1995-2028, 2006

39 Yamada T, "Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease." 53 : 783-788, 2006

40 Vitti P, "Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment." 7 : 369-375, 1997

41 Tada H, "Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease." 58 : 403-408, 2003

42 Quadbeck B, "Basedow Study Group. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease." 15 : 1047-1054, 2005

43 Shulman D.I, "Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy." 7 : 755-760, 1997

44 Smith B.R, "Autoantibodies to the thyrotropin receptor." 9 : 106-121, 1988

45 Rivkees S.A, "An optimal treatment for pediatric Graves' disease is radioiodine." 92 : 797-800, 2007

46 Allahabadia A, "Age and gender predict the outcome of treatment for Graves' hyperthyroidism." 85 : 1038-1042, 2000